-
-15%
LEVADOL GEL 40M SIR 2ML / 40MG
71.25€
83.82€
- Brand: DIFASS INTERNATIONAL SpA
- Product Code: 982501708
- EAN: 8052744660141
- Availability: In Stock
- Purchase 3 items for 69.83€ each
- Purchase 4 items for 68.40€ each
- Purchase 5 items for 66.98€ each
Levadol M
Description
Class III Medical Device (Directive 93/42 / EEC). Single use. Sterile.
Substitute for synovial fluid which, thanks to its viscoelastic and lubricating properties, favors the restoration of the rheological conditions of the altered joints in patients with degenerative osteoarthritis. By improving the characteristics of the synovial fluid, the product exerts a protective action on the joints with a consequent improvement in joint function and the reduction of painful symptoms. Levadol M acts only at the level of the joint where it is injected, without exerting any systemic action.
LEVADOL M is a sterile injectable, biodegradable and isotonic gel, for intra-articular use. Levadol M consists of a medium molecular weight hyaluronic acid (1.5-2.5 x 106 Dalton), produced by Streptococcus equi bacteria, formulated at a concentration of 20 mg / ml in a physiological buffer. Levadol M is characterized by viscoelastic properties, therefore it allows to promote the normalization of the viscosity of the synovial fluid present in the intra-articular cavity. Each pack contains one Levadol M syringe vial and one leaflet. There are two labels showing the lot number and expiry date. One of these labels must be applied to the patient's medical record and the other must be given to the patient to ensure traceability.
How to use
Remove any joint effusion before injecting Levadol M. Remove the protective cap of the syringe taking special care to avoid contact with the opening. Firmly screw the needle with a diameter between 18 and 22 G to the Luer-type locking collar following the instructions below. Before injection, treat the site with suitable disinfectant. Inject LevadolM using an aseptic technique. Inject into the intra-articular cavity only. The use of Levadol M is at the discretion of the physician. Levadol M should be used according to the needs of individual patients, the area and the pathology to be treated.
Assembling the needle on the syringe:
- Carefully unscrew the cap from the tip of the syringe, paying particular attention to avoid contact with the opening.
- Gently grasp the needle guard and fit the needle onto the luer-lock connector, screwing firmly until a slight back pressure is felt to ensure a watertight seal and prevent leakage of the gel during administration.
Components
Sodium hyaluronate 20 mg / ml, sodium chloride, monobasic sodium phosphate dihydrate, dibasic sodium phosphate dodecahydrate, ppi water
Warnings
Keep out of reach of children. Levadol M is only indicated for intra-articular injections and should only be dispensed by a physician who has received specific training on intra-articular injection technique. Before use, check the integrity of the syringe and the expiration date. Do not use needles other than those indicated. The product should not be injected in the presence of an infected or severely inflamed joint. Infiltration should be avoided in case of ongoing infections or inflammatory conditions of the skin near the site of infiltration. It is advisable to advise the patient, after the intra-articular injection, to avoid demanding physical activities for the joint and to resume normal activities after a few days.
The outside of the syringe is not sterile. Levadol M has not been tested in pregnant or lactating women and is therefore not recommended for use in these cases. L
Class III Medical Device (Directive 93/42 / EEC). Single use. Sterile.
Substitute for synovial fluid which, thanks to its viscoelastic and lubricating properties, favors the restoration of the rheological conditions of the altered joints in patients with degenerative osteoarthritis. By improving the characteristics of the synovial fluid, the product exerts a protective action on the joints with a consequent improvement in joint function and the reduction of painful symptoms. Levadol M acts only at the level of the joint where it is injected, without exerting any systemic action.
LEVADOL M is a sterile injectable, biodegradable and isotonic gel, for intra-articular use. Levadol M consists of a medium molecular weight hyaluronic acid (1.5-2.5 x 106 Dalton), produced by Streptococcus equi bacteria, formulated at a concentration of 20 mg / ml in a physiological buffer. Levadol M is characterized by viscoelastic properties, therefore it allows to promote the normalization of the viscosity of the synovial fluid present in the intra-articular cavity. Each pack contains one Levadol M syringe vial and one leaflet. There are two labels showing the lot number and expiry date. One of these labels must be applied to the patient's medical record and the other must be given to the patient to ensure traceability.
How to use
Remove any joint effusion before injecting Levadol M. Remove the protective cap of the syringe taking special care to avoid contact with the opening. Firmly screw the needle with a diameter between 18 and 22 G to the Luer-type locking collar following the instructions below. Before injection, treat the site with suitable disinfectant. Inject LevadolM using an aseptic technique. Inject into the intra-articular cavity only. The use of Levadol M is at the discretion of the physician. Levadol M should be used according to the needs of individual patients, the area and the pathology to be treated.
Assembling the needle on the syringe:
- Carefully unscrew the cap from the tip of the syringe, paying particular attention to avoid contact with the opening.
- Gently grasp the needle guard and fit the needle onto the luer-lock connector, screwing firmly until a slight back pressure is felt to ensure a watertight seal and prevent leakage of the gel during administration.
Components
Sodium hyaluronate 20 mg / ml, sodium chloride, monobasic sodium phosphate dihydrate, dibasic sodium phosphate dodecahydrate, ppi water
Warnings
Keep out of reach of children. Levadol M is only indicated for intra-articular injections and should only be dispensed by a physician who has received specific training on intra-articular injection technique. Before use, check the integrity of the syringe and the expiration date. Do not use needles other than those indicated. The product should not be injected in the presence of an infected or severely inflamed joint. Infiltration should be avoided in case of ongoing infections or inflammatory conditions of the skin near the site of infiltration. It is advisable to advise the patient, after the intra-articular injection, to avoid demanding physical activities for the joint and to resume normal activities after a few days.
The outside of the syringe is not sterile. Levadol M has not been tested in pregnant or lactating women and is therefore not recommended for use in these cases. L